For children with severe Crohn disease, upadacitinib offers an effective induction therapy, but its benefits must be carefully weighed against potential adverse events.

Here’s what to know about Crohn’s disease and alcohol, including whether it’s safe to drink during flares or while on medication.

Crohn’s disease and celiac disease are both gastrointestinal (GI) conditions that can cause abdominal pain, diarrhea, and other symptoms. While both diseases cause inflammation in the GI tract ...

Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease.

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease, according to findings published in Science Immunology. The ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction options for adults with moderate to severe active Crohn disease.

Understanding the signs and symptoms of Crohn’s disease is crucial for early diagnosis, which can lead to more effective management of the condition. Here are the key indicators that might ...

Gastrointestinal (GI) bleeding is a common and potentially life-threatening condition that requires prompt and accurate diagnosis.

Researchers at the University of Gothenburg have uncovered a critical mechanism that may pave the way for innovative treatments for Crohn's disease. Their findings center on repairing the ...

Crohn’s disease isn’t just about digestion. From joint pain to vision issues, its hidden symptoms affect the body in unexpected ways.

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.

Every year, more and more Americans are being diagnosed with inflammatory bowel disease. Who’s at risk for IBD, and what are the warning signs?